April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
A 27-Gauge Instrument System for Transconjunctival Micro-Incision Vitrectomy Surgery
Author Affiliations & Notes
  • T. Wakabayashi
    Osaka University Medical School, Suita, Japan
  • Y. Oshima
    Osaka University Medical School, Suita, Japan
  • T. Sato
    Osaka University Medical School, Suita, Japan
  • Y. Tano
    Osaka University Medical School, Suita, Japan
  • Footnotes
    Commercial Relationships  T. Wakabayashi, None; Y. Oshima, None; T. Sato, None; Y. Tano, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 5205. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T. Wakabayashi, Y. Oshima, T. Sato, Y. Tano; A 27-Gauge Instrument System for Transconjunctival Micro-Incision Vitrectomy Surgery. Invest. Ophthalmol. Vis. Sci. 2009;50(13):5205. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate the efficiency, safety, and feasibility of a 27-gauge instrument system for transconjunctival microincision vitrectomy surgery (MIVS).

Methods: : We developed a 27-gauge instrument system that includes a vitreous cutter, an infusion line, membrane forceps, chandelier fibers, laser probes, and a trocar-cannula system. The infusion and aspiration rates were evaluated using balanced saline with different aspiration powers. The duty cycle of the 27-gauge vitreous cutter was evaluated based on frame-by frame analysis using a high-speed imaging camera and compared with that of a conventional 25-gauge cutter with different cutter velocities. In a pilot study, 28 eyes of 28 patients underwent transconjunctival 27-gauge MIVS for a variety of vitreoretinal diseases, including idiopathic epiretinal membrane (n=14), vitreous biopsy (n=4), macular hole (n=3), diabetic vitreous hemorrhage (n=3), diabetic traction retinal detachment (n=3), and macular traction syndrome (n=1). Surgical outcomes including anatomic success, visual recovery, and postoperative wound-sealing related complications were evaluated.

Results: : Although the infusion and aspiration rates of the 27-gauge system were 30% lower than that of the 25-gauge system, the 27-gauge cutter duty cycle, 61% at 1,000 cuts/minute (cpm) and 38% at 1,500 cpm, was equal to or better than that of the conventional 25-gauge cutter (62% and 28%, respectively).Based on fluid dynamics analysis, the vented gas-forced infusion can be set in the range of 20 to 30 mmHg for safely controlling the intraocular pressure (IOP) during 27-gauge vitrectomy. Anatomic success was achieved in all study eyes (100%); 21 eyes (70%) had visual recovery exceeding 0.3 logMAR unit using the 27-gauge system. No eyes required conversion to larger gauge instruments intraoperatively. All sclerotomies self-sealed without hypotony (IOP ≤7 mmHg) from 1 day postoperatively.

Conclusions: : The fluid dynamics and cutting efficiency of the new 27-gauge system are similar to that of the conventional 25-gauge system. Transconjunctival 27-gauge MIVS is feasible and safe for selected vitreoretinal disorders.

Keywords: vitreoretinal surgery 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.